Prot # MDV1634-04: A Phase 1, Multicenter, Randomized, Double Blind, Placebo-Controlled, Safety and Dose Finding Biomarker Study of MDV1634 in Patients with Parkinson's Disease

Project: Research project

Project Details

StatusFinished
Effective start/end date3/11/143/11/15

Funding

  • Medivation, Inc. (Prot # MDV1634-04)